Seed VC · Switzerland
The Novartis Venture Fund invests to 'foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies' working in biotechnology and biopharmaceuticals across a wide array of therapeutic areas.
Business models
deeptech_ip
Customer segments
Enterprise
Geography
US, Europe
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Novartis Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Novartis Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Novartis Ventures is one of them — and we'll tell you exactly where they sit in your top 100.